Treatment patterns of rheumatoid arthritis in Japanese hospitals and predictors of the initiation of biologic agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment patterns of rheumatoid arthritis in Japanese hospitals and predictors of the initiation of biologic agents

Published:2016-10-03 Issue:1 Volume:33 Page:101-107
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Mahlich Joerg¹²,Sruamsiri Rosarin¹³

Affiliation:

1. Janssen Pharma Kabushiki Kaisha, Nishi Kanda, Chiyoda-ku, Japan;

2. Heinrich-Heine-Universitat Dusseldorf Wirtschaftswissenschaftliche Fakultat Dusseldorf, Germany;

3. Center of Pharmaceutical Outcomes Research, Naresuan University, Phitsanulok, Thailand

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1239191

Reference31 articles.

1. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)

2. Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study

3. Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRA

4. The Indirect Costs of Arthritis Resulting From Unemployment, Reduced Performance, and Occupational Changes While at Work

5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study;BMJ Open;2024-02

2. Benchmarking tocilizumab use for giant cell arteritis;Rheumatology Advances in Practice;2022

3. Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis;Intestinal Research;2021-10-31

4. Effects of Denosumab in Japanese Patients With Rheumatoid Arthritis Treated With Conventional Antirheumatic Drugs: 36-month Extension of a Phase III Study;The Journal of Rheumatology;2021-04-15

5. Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction;RMD Open;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3